Mutations of the leucine-rich glioma-inactivated 1 (LGI1) gene cause an autosomal-dominant partial epilepsy with auditory features also known as autosomal-dominant lateral temporal lobe epilepsy (ADLTE). Furthermore, LGI1 is the main antigen present in sera and cerebrospinal fluids of patients with limbic encephalitis and seizures, highlighting the importance of LGI1 in a spectrum of epileptic disorders.
INTRODUCTION
Epilepsy, with a lifetime prevalence of 3%, is a frequent neurological disorder. Studies on familial idiopathic epilepsies have identified multiple disease-causing genes (1) . For example, mutations in the leucine-rich glioma-inactivated 1 (LGI1) gene cause an inherited epilepsy syndrome designated either Autosomal Dominant Lateral Temporal Epilepsy (ADLTE) (2) or Autosomal Dominant Partial Epilepsy with Auditory Features (ADPEAF) (3) . Focal seizures, with prominent auditory auras in about two thirds of patients, emerge in adolescence (4).
Aphasic symptoms and other aberrant perceptions of a visual, vertiginous, epigastric, or psychogenic nature are also reported, and seizures can be triggered by noises or voices (5, 6).
This seizure semiology tends to indicate a neocortical origin in the lateral temporal lobe.
LGI1 mutations (36 published to date (7) ) have been found in up to 50% of ADLTE families and 2% of sporadic cases (8) . The role of LGI1 in neurological diseases was further expanded with the recent discovery that a subset of patients with limbic encephalitis (an autoimmune disorder associated with seizures in the majority of patients) (9, 10) has serum antibodies against LGI1. It is speculated that antibody-mediated disruption of LGI1 causes increased excitability, which results in seizures and other symptoms of limbic encephalopathy.
In contrast to other genes linked to idiopathic epilepsies, LGI1 does not encode an ion channel subunit, but rather a secreted leucine-rich repeat (LRR) protein (11) . To the exception of R407C (12) , all tested LGI1 missense mutations tend to suppress protein secretion in in vitro overexpression systems (11, (13) (14) (15) (16) (17) , indicating that extracellular levels of LGI1 may be critical to its pathophysiological effects. Lgi1 protein is expressed in the developing brain during embryogenesis and increases until adult, suggesting that Lgi1 may have a role during brain development (18) (19) (20) . While its functions remain unclear, Lgi1 interacts with the presynaptic Kv1.1 voltage-gated potassium channel (21), ADAM22/ADAM23 (disintegrin and metalloproteinase domain 22 and 23)(22), ADAM11 (23) and NogoR1 (24). Insights into the role of Lgi1 in epilepsy have emerged from recent studies on Lgi1 knockout in mice.
There is a consensus that in homozygous Lgi1 -/mice, the constitutive deletion of Lgi1 induces early-onset spontaneous seizures with a premature death (19, 25, 26) . Heterozygous Lgi1 +/mice do not generate seizures spontaneously, but they are more susceptible to seizure induction by pentylenetetrazole (25) and auditory stimuli (19) . Suppression of Lgi1 may be epileptogenic by modulating signaling in glutamatergic but not GABAergic synaptic transmissions (25, 26) as well as controlling postnatal maturation and pruning of glutamatergic synapses in the hippocampus (20) and retinogeniculate afferents in the thalamus (27) .
In the present study, we generated and characterized Lgi1-mutant rats carrying a missense mutation (L385R). We deciphered the mechanisms by which this mutation led to a loss of function in mammalian cells and primary neurons in culture. Electroencephalographic (EEG) monitoring was then used to define how the L385R-Lgi1 protein affected the phenotype of homozygous and heterozygous Lgi1-mutant rats in vivo. Finally, we examined actions of antiepileptic drugs on the audiogenic seizures in heterozygous Lgi1 +/L385R rats.
RESULTS

Generation of Lgi1-mutant rats
The ENU (N-ethyl-N-nitrosourea)-mutagenized F344/NSlc rat archive (KURMA: Kyoto University Rat Mutant Archive) was screened for mutations in the Lgi1 gene by a highthroughput screening assay (28) . A missense mutation (c.1154 T>G) in exon 8 of Lgi1 was found in one DNA sample of KURMA. This mutation resulted in the p.Leu385Arg/L385R amino acid substitution in the fourth epilepsy-associated-repeat (EAR) ( Figure 1A ), a residue highly conserved among vertebrates and invertebrates ( Figure 1B ). It was predicted to be "not tolerated" by the SIFT prediction tool of functional effects of variants (http://blocks.fhcrc.org/sift/SIFT.html). Interestingly, a well-documented ADLTE-causing mutation, p.Glu383Ala/E383A, was located close to the Rat mutation (3, 11, 13) . The heterozygous Lgi1-mutant rat (Lgi1 +/L385R ) was recovered from the corresponding frozen sperm by intracytoplasmic sperm injection. Nine generations were backcrossed on the F344/NSIc inbred background to eliminate mutations potentially induced by ENUmutagenesis elsewhere in the genome (mean mutation frequency was ~1 in 4 x 10 6 base pairs).
Backcrossed Lgi1 +/L385R rats were then intercrossed to obtain wild-type (WT), heterozygous (+/L385R) and homozygous (L385R/L385R) animals. They were born in expected Mendelian ratios (+/+, n=17; homozygous, n=18; heterozygous, n=29; ² = 0.59, not significant) and sex ratios (Lgi1 L385R/L385R rats: 28 females, 36 males; ² = 1, not significant).
L385R mutation impairs Lgi1 secretion in COS7 cells and cortical neurons
We asked whether the rat L385R mutation impaired Lgi1 secretion, by transiently transfecting COS7 cells with Flag-Lgi1-L385R, Flag-Lgi1-E383A or Flag-Lgi1-WT (wild-type Lgi1).
Using an antibody directed against amino acids 200-300 of Lgi1 (ab30868), Western blot analysis revealed the presence of wild-type Lgi1 and both mutants in the cell lysates.
However, while wild-type Lgi1 protein was predominantly present in the cell culture medium, we did not detect the Flag-Lgi1-L385R or the Flag-Lgi1-E383A mutants (Figure 2A ). This shows that the L385R mutation prevents secretion of Lgi1 into the culture medium of COS7 cells.
We next examined endogenous Lgi1 secretion in isolated neurons of primary cortical cultures from embryonic day 19 Lgi1 L385R/L385R , Lgi1 +/L385R and Lgi1 +/+ littermates. Western blot analysis revealed only weak signal of 65 kDa in the neuron lysate of homozygous Lgi1 L385R/L385R rats, as well as in the neuron medium, indicating a low level of L385R-Lgi1 protein in neurons ( Figure 2B ).
L385R mutation affects in vivo stability of Lgi1 protein
We then compared the endogenous L385R-Lgi1 protein level by Western blot in whole brain homogenates of P12 Lgi1 L385R/L385R , Lgi1 +/L385R and wild-type (Lgi1 +/+ ) littermate rats.
Immunoblot revealed a single band of 65 kDa in the lysate of Lgi1 +/+ . It was reduced by about half in Lgi1 +/L385R and was absent in Lgi1 L385R/L385R (n=5; Figure 3A) . The low abundance of L385R-Lgi1 protein in brain was confirmed with a second antibody generated to the C-terminus of Lgi1 (sc-9583, Santa Cruz) in whole brain lysates from P9 rats ( Figure   1S , supplementary data). These findings were replicated in 3 additional litters of wild type, heterozygous and homozygous rats aged P5 and P9 (before onset of seizures) and P12 (after onset of seizures), indicating that shortened half-life of L385R-Lgi1 was not due to seizuresinduced damage (data not shown). We next analyzed synaptic fractions of hippocampal and cortical lysates by preparing Triton X100-soluble crude fractions. In Lgi1 +/+ and Lgi1 +/L385R rats, a strong signal was detected, indicating Lgi1 protein was present at the synapse. In contrast, similarly to whole brain homogenates, L385R-Lgi1 protein was not detected in the synaptic membrane fraction ( Figure 3B ), suggesting that it is probably unstable and thus not delivered to the synapse.
We next asked whether low levels of L385R-Lgi1 protein resulted from a preferential degradation of L385R-Lgi1 transcript. We extracted total RNAs from whole brains of Lgi1 L385R/L385R (n=5), Lgi1 +/L385R (n=7) and Lgi1 +/+ (n=5) littermate rats and analyzed Lgi1 transcript expression by quantitative RT-PCR. Relative levels of the L385R-Lgi1 transcript were not significantly different from levels of the Lgi1 +/+ transcript (Kruskal-Wallis test, P non significant; Figure 3C ). These results suggest that low neuronal levels of L385R-Lgi1 protein may result from a rapid turnover of the protein rather than the transcript.
L385R mutation has no major effect on in vitro neuronal growth
We asked whether this L385R mutation modified the growth of primary neurons plated on poly-L-lysine coated culture vessels. Cortical and hippocampal neurons from E19 rats were co-cultured for 3 weeks and examined daily. No differential effect on life span or neurite outgrowth was detected between Lgi1 L385R/L385R and Lgi1 +/+ rats (Image J measurement of total neurite network length, Kruskal-Wallis test, P non significant) ( Figure 4A ). No major morphological differences were detected between hematoxylin-stained brains of P12 Lgi1 L385R/L385R rats and their Lgi1 +/L385R and Lgi1 +/+ littermates ( Figure 4B ).
Homozygous Lgi1-mutant rats are epileptic and die prematurely
At birth, we detected no differences in appearance or behavior of homozygous Lgi1 L385R/L385R rats and heterozygous Lgi1 +/L385R and Lgi1 +/+ littermates. During the second postnatal week, Lgi1 L385R/L385R pups began to exhibit spontaneous seizures ( Figure 5A Hz during jerking episodes which slowed (0.5 Hz) as the seizure terminated. Seizures were sometimes associated with motor automatisms, such as chewing. Such spontaneous epileptic activity was never observed in age-matched heterozygous Lgi1 +/L385R (n=7) or Lgi1 +/+ littermates (n=7).
As seizures emerged, Lgi1 L385R/L385R rat pups began to lose body weight. At P15, the body weight of Lgi1 L385R/L385R rats was significantly (P<0.009, t-test) lower than that of Lgi1 +/L385R
or Lgi1 +/+ rats ( Figure 6A ), and development slowed dramatically ( Figure 6B ). All homozygous Lgi1 L385R/L385R rats died prematurely and the Kaplan-Meier curve revealed a mean lifetime of 13 days (n= 10). No homozygous Lgi1 L385R/L385R rat survived beyond P17, while no Lgi1 +/L385R or Lgi1 +/+ littermates had died at this age ( Figure 6C ). Possibly, this early mortality results from a failure to feed due to seizures.
Heterozygous Lgi1-mutant rats display increased audiogenic seizure vulnerability
Heterozygous Lgi1 +/L385R rats appear normal, are fertile and live for at least one year.
Spontaneous clinical seizures have never been observed either in pups or adults. Since partial seizures can be triggered by audiogenic events in ADLTE patients, we tested the susceptibility of heterozygous Lgi1-mutant rats to audiogenic seizures (AGS). A single 120 dB sound stimulus at 10 kHz never induced a seizure in Lgi1 +/L385R or Lgi1 +/+ rats at 3, 5, 8 or 12 weeks of age, possibly due to this rat strain resistance. Acoustic priming (5 min, 10 kHz, 120 dB) was thus applied to rat pups aged P16, corresponding to the critical period when rats become seizure-prone (29) . Primed rats were then tested for audiogenic seizures at 8 weeks of age. Auditory stimulus first induced wild running, a typical behavior of audiogenic seizures, in all Lgi1 +/L385R (n=22) and Lgi1 +/+ (n=14) rats at 8 weeks (Table 1) . Following wild running, we noted that auditory stimulation yielded generalized tonic-clonic seizures (GTCS) in all Lgi1 +/L385R rats, but only in 28 % of Lgi1 +/+ rats (100 % versus 28 %,  2 =36, P =1.9 10 -9 ) ( Figure 7A , movie 2). The latency from auditory stimulus to wild running was shorter in Lgi1 +/L385R than Lgi1 +/+ rats (Student's t test, P=2.7 10 -2 ; Figure 7B ). The duration of wild running was also shorter in Lgi1 +/L385R than in Lgi1 +/+ rats, probably since wild running was more rapidly replaced by a GTCS in Lgi1 +/L385R rats (Student's t test, P=6. 8 10 -5 ; Figure 7C ).
The duration of GTCS did not differ significantly in Lgi1 +/L385R and Lgi1 +/+ rats (Student's t test, P=4.5 10 -1 ; Figure 7D ).
We compared cortical and hippocampal EEG signals generated by Lgi1 +/L385R (n=3) and
Lgi1 +/+ rats (n=1) during auditory stimuli ( Figure 8 ). During wild running, movement artifacts tended to obscure EEG signals. After running terminated, EEG signals were strongly suppressed in the tonic phase of Lgi1 +/L385R rats and the immobility phase of Lgi1 +/+ rats.
During the clonic seizure phase in Lgi1 +/L385R rats, continuous rhythmic slow activity at 2-3 Hz was detected in cortex and hippocampus. EEG signals were then suppressed, as Lgi1 +/L385R rats remained immobile until auditory stimuli ceased.
Effect of antiepileptic drugs on audiogenic seizures
Finally, we evaluated the efficacy of several antiepileptic drugs on audiogenic seizures in primed Lgi1 +/+ and Lgi1 +/L385R rats. We administered carbamazepine, phenytoin, levetiracetam and ethosuximide intraperitoneally (20 mg/kg) at 30 min before the auditory stimuli in 8
week-old rats ( 
DISCUSSION
Here we present the first genetically-engineered animal model to express a missense mutation in the Lgi1 gene. We generated and characterized a Lgi1-mutant rat with a missense mutation (L385R) and studied its functional consequences in vivo. We first examined the impact of the mutation using in vitro overexpression paradigm. Our results showed that this mutation prevented Lgi1 secretion in transiently transfected COS7 cells. This variant is thus deleterious and apparently shares common effects with ADLTE-causing missense mutations which nearly all decrease protein secretion, except one (30) . Testing endogenous expression levels of the mutated Lgi1 protein in cultured cortical neurons of Lgi1-mutant animals revealed very low levels of L385R-Lgi1 protein, both in extracellular medium from cultures and also in neuron lysates. Moreover, endogenous levels of Lgi1 protein were also substantially lower in the brain of Lgi1-mutant animals than of wild-type littermates. Probably, in vivo, the L385R mutation favors misfolding and so reduces Lgi1 protein stability, causing its degradation through protein quality control mechanisms. This is consistent with in silico computational models predicting that a number of disease-causing mutations alter protein folding (30) . Thus a physiopathological loss-of-function may emerge not only due to a failure of protein secretion but also from a lack of correctly folded neuronal Lgi1. This new mechanism must be considered together with previous suggestions of a defective secreted extracellular Lgi1
(acting as a ligand for ADAM22/23 at the post-synaptic) (22), rather than cytoplasmic (through the modulation of Kv1.1 channel) (21). Here, the Lgi1-mutant rat carrying a missense mutation located nearby a well-characterized naturally occurring missense mutation found in ADLTE patients (3, 11, 13) , lacks both cytoplasmic and extracellular Lgi1. While cortical tissue from patients is not available, we speculate that ADLTE-associated missense mutations might also lead to instability in vivo, causing a haploinsufficiency. We note such a deficiency in Lgi1 occurs in patients with limbic encephalitis and seizures, in which immunemediated disruption of LGI1 results in hyperexcitability (31) .
While focal epilepsies are often associated with brain lesions, we detected no major abnormality in brain morphology of Lgi1-mutant rats. Since Lgi1 may promote neurite outgrowth in vitro via ADAM23 (32) and NogoR1 (24), we examined neuron growth in cocultures of cortical and hippocampal neurons from Lgi1-mutant rats. We detected no obvious defect in neuritic outgrowth or neuronal life-span suggesting that neuronal network activity, rather than dendritic architecture may contribute to hyperexcitability in this rat. EEG pattern and premature death associated with loss of body weight), (ii) an absence of morphological abnormalities, (iii) audiogenic seizures in heterozygous rats recapitulating the genetic cause and mimicking the auditory triggering of seizure in the human. We note the similar age of seizure onset (around P10) in Lgi1-null mice and Lgi1-mutant rats that might be consistent with the timing of Lgi1 expression and maturation of glutamatergic synapses similar to both species. We were initially surprised to define a similar phenotype in homozygous Lgi1-mutant rats (L385R-Lgi1) and Lgi1-null mice (absence of Lgi1). However, our discovery of a rapid degradation of Lgi1-L385R suggests the point mutation induces a haploinsufficiency that is equivalent to a gene knockout.
In conclusion, we report a unique and original rat model of Lgi1-related epilepsies, which is complementary to knockout mice. It gave us the opportunity to better understand the consequences of missense mutations on the fate of the mutant protein, revealing a major finding that L385R-Lgi1 protein is unstable in vivo. Thanks to this model, we also investigated the consequences of Lgi1 deficiency on the neuronal and neurite outgrowth.
Finally, the heterozygous Lgi1 +/L385R rats allowed us to initiate pharmacological studies on their auditory triggered-seizures which are close to those occurring in ADLTE patients.
MATERIAL AND METHODS
ENU mutagenesis in rats
ENU mutagenesis and screening protocols using MuT-POWER in rats have been described (28) . The sperm archive KURMA has been deposited in the National BioResource Project-Rat in Japan (NBRP-Rat: www.anim.med.kyoto-u.ac.jp/nbr). Primers were designed to amplify by PCR the exonic region of the rat Lgi1 gene from ~50 bp flanking each intron (supplemental Table 1 ). Sequencing was performed with BigDye terminator mix, followed by the protocol for the Applied Biosystems 3100 DNA Sequencer. Lgi1-mutant rats were recovered from frozen sperm by intracytoplasmic sperm injection.
Animals
Lgi1-mutant rats (strain name, F344-Lgi1 m1kyo ) were deposited in NBRP-Rat (N° 0656 Cell lysates and conditioned media were prepared as described (13) and analyzed by Western blot.
Neuronal cultures
Cortex and hippocampus were removed from ten rat embryos aged embryonic day 19 (E19) and dissociated using the Nerve-Cell culture system (Sumitomo Bakelite co). Neurons were plated at 10 5 cells/ml in neuron culture medium (Sumitomo Bakelite co) on 35mm poly-L-Lysine coated dishes. They were cultured for 12 days and then lysed as previously described in COS7 cells. Neuronal outgrowth was imaged and measured automatically using ImageJ.
Quantitative reverse transcription PCR
Whole brains were removed from P9 rats (n=6) and stored in RNAlater® solution (Applied Biosystems 
Animal surgery and intracranial EEG recordings
Cortical EEG was recorded from homozygous P10 rats (during 3 continuous hours) and heterozygous rats aged 8 weeks. Rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (40 mg/kg) and the heads were fixed in a stereotaxic instrument. Onemm-diameter screw electrodes were implanted into the epidural space of the left frontal cortex.
A reference electrode was fixed on the frontal cranium. For hippocampal EEG, 0.2-mmdiameter stainless-steel electrodes were implanted in the hippocampus (3.8 mm caudal, 2.0 mm lateral to the bregma and 2.2 mm from the cortex surface). A miniature plug was positioned and fixed on the midline of the skull to provide electrical connections. After 1-hour recovery period for P10 rats and 1-week recovery period for 8-week old rats, animals were placed in a shielded box (40×40×40 cm 3 ) and the EEG signals were amplified with a sampling rate of 0.5-100 Hz with a 8-channel system (MEG-6108; Nihon Kohden) and
recorded (RTA-1100; Nihon Kohden) under free-moving conditions. The signals were stored in a computer for analysis (ML845; PowerLab). Behavioral changes were simultaneously observed with video recording.
Acoustic stimulation
The testing apparatus consisted of a 17×25×13 cm plastic cage placed inside a larger soundproof box. Acoustic stimulation was administered from a loudspeaker (JBL Professional) centrally placed on the cover of the cage. Tone bursts were delivered by a sound stimulator (DPS-725, Dia Medical System Co.) and the signal was amplified using a power amplifier (D75-A, Amcron). Lgi1 +/L385R and Lgi1 +/+ littermate rats were exposed individually to intense auditory stimulation after 1-minute habituation. Priming stimulation was performed in P16 rats with a sound stimulus of 120 dB at 10 kHz for 5 min. Target stimulation consisted of a 120 dB sound stimulus at 10 kHz for 1 min at 8 weeks (36) . The onset, latency, and duration of wild running and GTCS were measured from video records.
Antiepileptic drugs administration
Antiepileptic drugs (Sigma-Aldrich) were administrated intraperitoneally 30 minutes before target stimulation with therapeutic range (20 mg/Kg). Carbamazepine and Ethosuximide were first dissolved in polyethylene glycol 400 then in water. Phenytoin was first dissolved in 0.5 N NaOH and then diluted with saline solution. Levetiracetam was dissolved in saline solution. 
